warfarin: be contraindicated in cancer

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents medication
Weight: 0.70
, drug
Weight: 0.65
, medicine
Weight: 0.60
, agent
Weight: 0.51
, blood clot
Weight: 0.50
Siblings naproxen
Weight: 0.37
, acetaminophen
Weight: 0.37
, aspirin
Weight: 0.37
, ibuprofen
Weight: 0.36
, vancomycin
Weight: 0.36

Related properties

Property Similarity
be contraindicated in cancer 1.00
be contraindicated in pregnancy 0.94
be contraindicated in hypertension 0.94
be contraindicated in endocarditis 0.91
be contraindicated in bacterial endocarditis 0.89
is teratogenic 0.78
be prescribed for atrial fibrillation 0.76
be prescribed for fibrillation 0.76
interact with aspirin 0.75

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.09
Rule weight: 0.13
Evidence weight: 0.75
Similarity weight: 0.94
Evidence: 0.62
¬ Remarkable(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.41
¬ Remarkable(ibuprofen, be contraindicated in pregnancy)

Remarkability from sibling implausibility

0.55
Rule weight: 0.60
Evidence weight: 0.97
Similarity weight: 0.94
Evidence: 0.93
Plausible(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.41
Remarkable(ibuprofen, be contraindicated in pregnancy) ⋁
Evidence: 0.79
¬ Plausible(ibuprofen, be contraindicated in pregnancy)

Salient implies Plausible

0.26
Rule weight: 0.28
Evidence weight: 0.93
Similarity weight: 1.00
Evidence: 0.93
Plausible(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.98
¬ Salient(warfarin, be contraindicated in cancer)

Similarity expansion

0.79
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.94
Evidence: 0.98
Salient(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.96
¬ Salient(warfarin, be contraindicated in pregnancy)
0.79
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.94
Evidence: 0.98
Salient(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.95
¬ Salient(warfarin, be contraindicated in hypertension)
0.78
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.94
Evidence: 0.97
Typical(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.87
¬ Typical(warfarin, be contraindicated in hypertension)
0.78
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.94
Evidence: 0.97
Typical(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.98
¬ Typical(warfarin, be contraindicated in pregnancy)
0.76
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.91
Evidence: 0.98
Salient(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.93
¬ Salient(warfarin, be contraindicated in endocarditis)
0.76
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.91
Evidence: 0.97
Typical(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.82
¬ Typical(warfarin, be contraindicated in endocarditis)
0.76
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.94
Evidence: 0.93
Plausible(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.85
¬ Plausible(warfarin, be contraindicated in hypertension)
0.75
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.94
Evidence: 0.93
Plausible(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.92
¬ Plausible(warfarin, be contraindicated in pregnancy)
0.74
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.89
Evidence: 0.98
Salient(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.96
¬ Salient(warfarin, be contraindicated in bacterial endocarditis)
0.74
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.89
Evidence: 0.97
Typical(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.89
¬ Typical(warfarin, be contraindicated in bacterial endocarditis)
0.73
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.91
Evidence: 0.93
Plausible(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.82
¬ Plausible(warfarin, be contraindicated in endocarditis)
0.71
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.89
Evidence: 0.93
Plausible(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.87
¬ Plausible(warfarin, be contraindicated in bacterial endocarditis)
0.66
Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 0.78
Evidence: 0.97
Typical(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.22
¬ Typical(warfarin, is teratogenic)
0.66
Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 0.78
Evidence: 0.98
Salient(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.62
¬ Salient(warfarin, is teratogenic)
0.65
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.78
Evidence: 0.93
Plausible(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.39
¬ Plausible(warfarin, is teratogenic)
0.64
Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 0.75
Evidence: 0.97
Typical(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.29
¬ Typical(warfarin, interact with aspirin)
0.64
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.94
Evidence: 0.62
Remarkable(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.54
¬ Remarkable(warfarin, be contraindicated in pregnancy)
0.63
Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 0.75
Evidence: 0.98
Salient(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.73
¬ Salient(warfarin, interact with aspirin)
0.63
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.76
Evidence: 0.98
Salient(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.98
¬ Salient(warfarin, be prescribed for atrial fibrillation)
0.63
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.76
Evidence: 0.98
Salient(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.93
¬ Salient(warfarin, be prescribed for fibrillation)
0.63
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.76
Evidence: 0.97
Typical(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.91
¬ Typical(warfarin, be prescribed for fibrillation)
0.63
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.76
Evidence: 0.97
Typical(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.97
¬ Typical(warfarin, be prescribed for atrial fibrillation)
0.62
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.75
Evidence: 0.93
Plausible(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.47
¬ Plausible(warfarin, interact with aspirin)
0.61
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.76
Evidence: 0.93
Plausible(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.86
¬ Plausible(warfarin, be prescribed for fibrillation)
0.61
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.76
Evidence: 0.93
Plausible(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.93
¬ Plausible(warfarin, be prescribed for atrial fibrillation)
0.58
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.94
Evidence: 0.62
Remarkable(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.73
¬ Remarkable(warfarin, be contraindicated in hypertension)
0.55
Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.91
Evidence: 0.62
Remarkable(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.76
¬ Remarkable(warfarin, be contraindicated in endocarditis)
0.55
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.89
Evidence: 0.62
Remarkable(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.72
¬ Remarkable(warfarin, be contraindicated in bacterial endocarditis)
0.50
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.76
Evidence: 0.62
Remarkable(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.60
¬ Remarkable(warfarin, be prescribed for atrial fibrillation)
0.49
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.76
Evidence: 0.62
Remarkable(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.63
¬ Remarkable(warfarin, be prescribed for fibrillation)
0.44
Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.78
Evidence: 0.62
Remarkable(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.89
¬ Remarkable(warfarin, is teratogenic)
0.42
Rule weight: 0.85
Evidence weight: 0.65
Similarity weight: 0.75
Evidence: 0.62
Remarkable(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.92
¬ Remarkable(warfarin, interact with aspirin)

Typical and Remarkable implies Salient

0.14
Rule weight: 0.14
Evidence weight: 0.99
Similarity weight: 1.00
Evidence: 0.98
Salient(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.97
¬ Typical(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.62
¬ Remarkable(warfarin, be contraindicated in cancer)

Typical implies Plausible

0.45
Rule weight: 0.48
Evidence weight: 0.94
Similarity weight: 1.00
Evidence: 0.93
Plausible(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.97
¬ Typical(warfarin, be contraindicated in cancer)

Typicality and Rermarkability incompatibility between siblings

0.06
Rule weight: 0.14
Evidence weight: 0.44
Similarity weight: 0.94
Evidence: 0.62
¬ Remarkable(warfarin, be contraindicated in cancer) ⋁
Evidence: 0.91
¬ Typical(ibuprofen, be contraindicated in pregnancy)